Internationally recognized biology contract research organization, GenScript USA Inc. has launched Epitope Mapping service to meet customers’ demand in antibody engineering.
http://www.genscript.com/
Epitope mapping is an indispensable component in antibody drug development and antibody therapeutics. It serves as a starting point in discovering antigen structure, designing appropriate mimic, understanding autoimmune diseases, and connecting a SNP polymorphism to a specific protein structure. GenScript’s epitope mapping services utilize its Proprietary FlexPeptideTM technology and optimized detection methods to increase accuracy and minimize unspecific interactions. Various epitopes can be mapped in one-stop services. “Epitope mapping has become more and more critical in both vaccine and antibody drug development. For vaccines, identification of conserved epitope among variants of a pathogen is a winning strategy to make functional vaccines. For drug development, knowledge on epitope of an antibody will largely facilitate its patent application. Our epitope mapping services can best serve researchers who are devoted in these fields.” said Oliver Zhang, the director of Antibody Drug Development department.
GenScript also has a peptide library platform. Overlapping peptide library can be constructed according to customer supplied sequence and then applied in the process of epitope screening against control and detection antibodies. Detailed data analysis will be delivered in a minimum of 4 weeks.
GenScript is a contract research organization (CRO) specialized in biological research and drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript has become a world-leading Biology CRO and the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.
